1. Home
  2. XBIT vs MFIN Comparison

XBIT vs MFIN Comparison

Compare XBIT & MFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$2.17

Market Cap

66.8M

Sector

Health Care

ML Signal

N/A

Logo Medallion Financial Corp.

MFIN

Medallion Financial Corp.

N/A

Current Price

$11.96

Market Cap

276.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
MFIN
Founded
2005
1995
Country
United States
United States
Employees
N/A
179
Industry
Pharmaceuticals and Biotechnology
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
66.8M
276.7M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
XBIT
MFIN
Price
$2.17
$11.96
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $12.00
AVG Volume (30 Days)
43.6K
★ 53.5K
Earning Date
05-08-2026
04-29-2026
Dividend Yield
N/A
★ 5.18%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.02
P/E Ratio
★ N/A
$6.21
Revenue Growth
N/A
★ N/A
52 Week Low
$2.09
$7.85
52 Week High
$3.44
$12.26

Technical Indicators

Market Signals
Indicator
XBIT
MFIN
Relative Strength Index (RSI) 40.04 54.54
Support Level N/A $11.40
Resistance Level $2.48 $12.26
Average True Range (ATR) 0.04 0.32
MACD 0.00 -0.08
Stochastic Oscillator 15.38 61.49

Price Performance

Historical Comparison
XBIT
MFIN

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About MFIN Medallion Financial Corp.

Medallion Financial Corp is a finance company that originates and services loans in various industries. The four operating segments are, (1) recreation, (2) home improvement, (3) commercial and (4) taxi medallion The company generates maximum revenue from the Recreation segment. The company's geographic Concentrations are in united states diversified in California, Wisconsin, New York, Texas and others.

Share on Social Networks: